ATF4 and plasma cell myeloma: In two statin-sensitive AML cell lines (25), OCI-AML3 and MOLM13, pitavastatin did not induce ATF4 and ISRIB did not affect sensitization to venetoclax, suggesting statin-mediated activation of the ISR is multiple myeloma specific (Supplementary Fig. S11).